0001574540-22-000073.txt : 20220303
0001574540-22-000073.hdr.sgml : 20220303
20220303163410
ACCESSION NUMBER: 0001574540-22-000073
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220301
FILED AS OF DATE: 20220303
DATE AS OF CHANGE: 20220303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lucey John W.
CENTRAL INDEX KEY: 0001581105
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36007
FILM NUMBER: 22709482
MAIL ADDRESS:
STREET 1: 309 N. WATER STREET, SUITE 500
CITY: MILWAUKEE
STATE: WI
ZIP: 53202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Physicians Realty Trust
CENTRAL INDEX KEY: 0001574540
STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798]
IRS NUMBER: 462519850
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 309 N. WATER STREET
STREET 2: SUITE 500
CITY: MILWAUKEE
STATE: WI
ZIP: 53202
BUSINESS PHONE: 414-367-5600
MAIL ADDRESS:
STREET 1: 309 N. WATER STREET
STREET 2: SUITE 500
CITY: MILWAUKEE
STATE: WI
ZIP: 53202
4
1
wf-form4_164634319322942.xml
FORM 4
X0306
4
2022-03-01
0
0001574540
Physicians Realty Trust
DOC
0001581105
Lucey John W.
309 NORTH WATER STREET
SUITE 500
MILWAUKEE
WI
53202
0
1
0
0
Chief Acctg. & Admin Officer
Common shares, $0.01 par value
2022-03-01
4
A
0
14185
0
A
147877
D
Common shares, $0.01 par value
2022-03-01
4
F
0
6145
16.37
D
141732
D
Common shares, $0.01 par value
400
I
Represents shares held by the Reporting Person's Spouse
2022 Performance Based Restricted Share Unit Grant
2022-03-01
4
A
0
21277
0
A
Common shares, $0.01 par value
21277.0
21277
D
Represents restricted common shares granted under the Issuer's 2013 Equity Incentive Plan (the "Plan"), which will vest on March 1, 2023, subject to the terms of the grant.
March 1, 2022 grant of performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. The exact number of shares to be issued upon vesting depends upon, among other things, the Issuer's financial performance. Subject to continued service, the shares, if any, will be issued following the performance period end date of December 31, 2024.
/s/ Christopher M. Bartoli, attorney-in-fact
2022-03-03